Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OG-6219 in Endometriosis-related Pain
2022-501310-57-00Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 2, randomised, double-blind trial of linustedastat in endometriosis (4 arms), sponsored by Organon & Co. Started Apr 2023; status: completed.
02
Drugs
linustedastat
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2022-501310-57-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501310-57-00.